Verrica Pharmaceuticals logo

Verrica Pharmaceuticals

VRCA | NASDAQ
Chart Builder DCF Calculator
$3.20
-$0.36 (-10.11%)
At close: Nov 16, 2026, 4:00 PM ET
$3.20
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-10.11%

Rating

Updated: Nov 16, 2026
53.5
+4.0 pts
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #212/1021 (Top 21%)

Key Statistics

Market Data

Market Cap $68.18M
1D Range
3.16 3.43
52W Range
3.09 9.10

Valuation (TTM)

PE -1.40
PB -11.41
EV/EBITDA -1.64

Valuation (NTM)

Forward PE N/A
Forward PEG -0.04
Price Target $9.00
Loading financial charts...

Profile

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The c...

Sector Healthcare
Industry Biotechnology
Employees 76
IPO Date Jun 15, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.58
Miss -16.60%
REV
$6.91M
Beat +11.51%
Next Earnings
Mar 10, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$9.00
Upside
+181.25%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.